OpenAlex
PricingAboutJobs
Log inGet started
Work

One‐year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment

HTML

Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2012.01634.x
Authors: W. Kothny, Q. Shao, P.‐H. Groop, V. Lukashevich
Institutions: Novartis (United States), Helsinki University Hospital
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: vildagliptin, type 2 diabetes, renal dysfunction, DPP-4 inhibitors, glycemic control, HbA1c, drug safety, adverse events, insulin therapy, long-term efficacy, glomerular filtration rate, placebo comparison, serious adverse events, drug discontinuation, mortality
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2154277743
FWCI: 9.959
Cites: 20
Cited by: 111
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security